Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07294118Phase 2Recruiting
A Phase 2 trial of lidocaine in Headache, subarachnoid hemorrhage (SAH), sponsored by The University of Texas Medical Branch at Galveston. Started Jan 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07294118.